ADAM17 抗体 (C-Term)
(1 reference)Quick Overview for ADAM17 抗体 (C-Term) (ABIN1030720)
抗原
See all ADAM17 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
特异性
- 80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
-
纯化方法
- Affinity chromatography purified via peptide column
-
-
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (AA 226-473) antibody
ADAM17 适用: 人 WB, IHC 宿主: 小鼠 Monoclonal C7 unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (AA 215-314) antibodyADAM17 适用: 人 WB, ELISA, IHC (p), PLA 宿主: 小鼠 Monoclonal 1F6 unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (AA 201-300) antibodyADAM17 适用: 人, 大鼠, 小鼠 WB, ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (AA 226-473) antibodyADAM17 适用: 人 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibodyVerified ADAM17 适用: 人 WB, ELISA 宿主: 山羊 Polyclonal unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibodyKO Validated ADAM17 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) antibodyADAM17 适用: 人, 大鼠, 小鼠 WB, FACS, IF (cc) 宿主: 兔 Monoclonal 9E7 unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (AA 215-315) antibodyADAM17 适用: 人 WB, ELISA, IHC, IHC (p), PLA 宿主: 小鼠 Monoclonal 1F6 unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (pThr735) antibodyADAM17 适用: 人, 大鼠, 小鼠 WB, ELISA, IHC, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibodyADAM17 适用: 人, 大鼠, 小鼠 WB, IF, EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
-
-
: "ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
-
: "ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
-
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
别名
- TACE
-
分子量
- Predicted: 93 kDa
-
途径
- Notch Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
抗原
-
